CYNTHIA GROENE: Open Payments
NPI 1376767863 · WINFIELD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,136 in 112 payments from 35 companies in 2025. Trend: 2023 $2,094 · 2024 $2,261 · 2025 $2,136
Food & beverage: $1,930Education: $206
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $320 |
| Novartis Pharmaceuticals Corporation | 17 | $289 |
| Janssen Biotech, Inc. | 13 | $183 |
| Merck Sharp & Dohme LLC | 7 | $135 |
| Daiichi Sankyo Inc. | 3 | $133 |
| PFIZER INC. | 8 | $129 |
| SEAGEN INC. | 1 | $95 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $62 |
| JAZZ PHARMACEUTICALS INC. | 3 | $51 |
Products named: Enhertu, KEYTRUDA, KISQALI, Fabhalta, RYBREVANT, SCEMBLIX, IBRANCE, CALQUENCE.
Industry payments across KS — which companies pay providers there.
